Shipping medical cannabis from South Africa to Germany

Farmer 2 Pharma secures long-term supply agreements between a licensed German importer and two licensed South African cultivators.
As the cannabis industry rollercoaster continues to persevere through painfully slow climbs and rapid dips, there is good news to share.
Farmer 2 Pharma is seeing an increase in interest from European licensed purchasers. "So much so that we have added a third African Medical Cannabis Roadshow to 2022, squeezing it in before the year ends and the German adult-use first draft is released."
"Shipping medical cannabis to Germany (The Holy Grail) is not easy. What is easy in the cannabis industry anyway?" the team says.
Germany will only accept the importation of medical cannabis that meets the defined EU-GMP standards, following the German monograph. "At the time of writing this article, no licensed cultivators in South Africa are EU-GMP certified, meaning that their produce are not acceptable for importing into the German market."

Farmer 2 Pharma is a solutions-driven business that takes challenging situations like this and finds the solution.

"Partnering with a CMO (contract manufacturer) in Malta and a CMO in Portugal, we are able to guide our clients (the cultivator) to be able to send their GACP (Good Agriculture and Collection Practise) certified products to the CMO who will process their GACP product into EU-GMP products and then the EU-GMP products can be shipped happily into the German market."
"We have secured two long-term supply contracts that follow this route, both supply chains running from South Africa, via Portugal, to Germany. The first two 100kg+ shipments have successfully been shipped, and the first batch of EU-GMP medical cannabis products are expected on German pharmacy shelves before the end of this month."

For more information:
Farmer 2 Pharma 

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.